TECH vs TERN
Bio-Techne Corp (TECH) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. TERN currently screens at market cap $6.12B.
Not investment advice. Open the TECH and TERN stock pages for the full models.
Not investment advice.